For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Travere Therapeutics Inc’s stock clocked out at $14.50, down -2.95% from its previous closing price of $14.94. In other words, the price has decreased by -$2.95 from its previous closing price. On the day, 1.58 million shares were traded.
Ratios:
To gain a deeper understanding of TVTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.03 and its Current Ratio is at 2.05. In the meantime, Its Debt-to-Equity ratio is 12.20 whereas as Long-Term Debt/Eq ratio is at 9.94.
On June 11, 2025, Citigroup reiterated its Buy rating and also upped its target price recommendation from $35 to $32.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 05 ’25 when Cline Christopher R. sold 1,784 shares for $21.05 per share. The transaction valued at 37,553 led to the insider holds 93,126 shares of the business.
Dube Eric M sold 18,924 shares of TVTX for $398,350 on May 05 ’25. The CHIEF EXECUTIVE OFFICER now owns 419,173 shares after completing the transaction at $21.05 per share. On May 05 ’25, another insider, Heerma Peter, who serves as the CHIEF COMMERCIAL OFFICER of the company, sold 1,771 shares for $21.05 each. As a result, the insider received 37,280 and left with 128,215 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.71 while its Price-to-Book (P/B) ratio in mrq is 39.22.
Stock Price History:
Over the past 52 weeks, TVTX has reached a high of $25.29, while it has fallen to a 52-week low of $6.80. The 50-Day Moving Average of the stock is -14.24%, while the 200-Day Moving Average is calculated to be -17.89%.
Shares Statistics:
A total of 88.79M shares are outstanding, with a floating share count of 87.50M. Insiders hold about 1.47% of the company’s shares, while institutions hold 112.64% stake in the company.
